Biobots Advance Soft Biological Machines
By LabMedica International staff writers Posted on 13 Jul 2014 |

Image: Tiny walking “bio-bots” are powered by muscle cells and controlled by an electric field (Photo courtesy of Janet Sinn-Hanlon, Design Group@VetMed).
A new generation of walking “biobots” powered by muscle cells and controlled with electrical pulses are providing researchers with never-before attained control over their function.
The engineers published their research in the online June 30, 2014, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS). “Biological actuation driven by cells is a fundamental need for any kind of biological machine you want to build,” said study leader Rashid Bashir, a professor and head of bioengineering at the University of Illinois at Urbana-Champaign (U of I; USA). “We’re trying to integrate these principles of engineering with biology in a way that can be used to design and develop biological machines and systems for environmental and medical applications. Biology is tremendously powerful, and if we can somehow learn to harness its advantages for useful applications, it could bring about a lot of great things.”
Prof. Bashir’s group has been innovators in designing and constructing bio-bots, less than 1 cm in size, made of flexible three-dimensional (3D)-printed hydrogels and living cells. Earlier, the engineers demonstrated biobots that “walk” on their own, powered by beating heart cells from lab rodents. However, heart cells continually contract, denying researchers control over the bot’s motion. This makes it difficult to use heart cells to engineer a biobot that can be turned on and off, sped up or slowed down.
The new biobots are powered by a band of skeletal muscle cells that can be triggered by an electric pulse. This gives the researchers a simple way to control the biobots and creates an avenue for other cutting-edge design ideas, so engineers can tailor biobots for specific applications. “Skeletal muscles cells are very attractive because you can pace them using external signals,” Prof. Bashir said. “For example, you would use skeletal muscle when designing a device that you wanted to start functioning when it senses a chemical or when it received a certain signal. To us, it’s part of a design toolbox. We want to have different options that could be used by engineers to design these things.”
The design is engineered similar to the muscle-tendon-bone complex found in nature. There is a support of 3D-printed hydrogel, strong enough to give the biobot structure but flexible enough to bend like a joint. Two posts serve to fasten a strip of muscle to the backbone, similar in the way tendons attach muscle to bone, but the posts also act as feet for the biobot. A bot’s speed can be controlled by adjusting the frequency of the electric pulses. A higher frequency causes the muscle to contract faster, thereby speeding up the biobot’s progress as seen in the video (below).
“It's only natural that we would start from a biomimetic design principle, such as the native organization of the musculoskeletal system, as a jumping-off point,” said graduate student Caroline Cvetkovic, co-first author of the paper. “This work represents an important first step in the development and control of biological machines that can be stimulated, trained, or programmed to do work. It's exciting to think that this system could eventually evolve into a generation of biological machines that could aid in drug delivery, surgical robotics, 'smart' implants, or mobile environmental analyzers, among countless other applications.”
Next, the researchers will work to gain even greater control over the biobots’ motion, such as integrating neurons so the biobots can be directed in different directions with light or chemical gradients. On the engineering side, they hope to design a hydrogel backbone that allows the biobot to move in different directions based on different signals. Due to 3D printing technology, engineers can examine different shapes and designs quickly. Prof. Bashir and colleagues even plan to integrate a unit into undergraduate lab curriculum so that students can design different kinds of biobots.
“The goal of ‘building with biology’ is not a new one--tissue engineering researchers have been working for many years to reverse engineer native tissue and organs, and this is very promising for medical applications,” said graduate student Ritu Raman, co-first author of the study. “But why stop there? We can go beyond this by using the dynamic abilities of cells to self-organize and respond to environmental cues to forward engineer non-natural biological machines and systems.”
“The idea of doing forward engineering with these cell-based structures is very exciting,” Prof. Bashir commented. “Our goal is for these devices to be used as autonomous sensors. We want it to sense a specific chemical and move towards it, then release agents to neutralize the toxin, for example. Being in control of the actuation is a big step forward toward that goal.”
Related Links:
University of Illinois at Urbana-Champaign
The engineers published their research in the online June 30, 2014, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS). “Biological actuation driven by cells is a fundamental need for any kind of biological machine you want to build,” said study leader Rashid Bashir, a professor and head of bioengineering at the University of Illinois at Urbana-Champaign (U of I; USA). “We’re trying to integrate these principles of engineering with biology in a way that can be used to design and develop biological machines and systems for environmental and medical applications. Biology is tremendously powerful, and if we can somehow learn to harness its advantages for useful applications, it could bring about a lot of great things.”
Prof. Bashir’s group has been innovators in designing and constructing bio-bots, less than 1 cm in size, made of flexible three-dimensional (3D)-printed hydrogels and living cells. Earlier, the engineers demonstrated biobots that “walk” on their own, powered by beating heart cells from lab rodents. However, heart cells continually contract, denying researchers control over the bot’s motion. This makes it difficult to use heart cells to engineer a biobot that can be turned on and off, sped up or slowed down.
The new biobots are powered by a band of skeletal muscle cells that can be triggered by an electric pulse. This gives the researchers a simple way to control the biobots and creates an avenue for other cutting-edge design ideas, so engineers can tailor biobots for specific applications. “Skeletal muscles cells are very attractive because you can pace them using external signals,” Prof. Bashir said. “For example, you would use skeletal muscle when designing a device that you wanted to start functioning when it senses a chemical or when it received a certain signal. To us, it’s part of a design toolbox. We want to have different options that could be used by engineers to design these things.”
The design is engineered similar to the muscle-tendon-bone complex found in nature. There is a support of 3D-printed hydrogel, strong enough to give the biobot structure but flexible enough to bend like a joint. Two posts serve to fasten a strip of muscle to the backbone, similar in the way tendons attach muscle to bone, but the posts also act as feet for the biobot. A bot’s speed can be controlled by adjusting the frequency of the electric pulses. A higher frequency causes the muscle to contract faster, thereby speeding up the biobot’s progress as seen in the video (below).
“It's only natural that we would start from a biomimetic design principle, such as the native organization of the musculoskeletal system, as a jumping-off point,” said graduate student Caroline Cvetkovic, co-first author of the paper. “This work represents an important first step in the development and control of biological machines that can be stimulated, trained, or programmed to do work. It's exciting to think that this system could eventually evolve into a generation of biological machines that could aid in drug delivery, surgical robotics, 'smart' implants, or mobile environmental analyzers, among countless other applications.”
Next, the researchers will work to gain even greater control over the biobots’ motion, such as integrating neurons so the biobots can be directed in different directions with light or chemical gradients. On the engineering side, they hope to design a hydrogel backbone that allows the biobot to move in different directions based on different signals. Due to 3D printing technology, engineers can examine different shapes and designs quickly. Prof. Bashir and colleagues even plan to integrate a unit into undergraduate lab curriculum so that students can design different kinds of biobots.
“The goal of ‘building with biology’ is not a new one--tissue engineering researchers have been working for many years to reverse engineer native tissue and organs, and this is very promising for medical applications,” said graduate student Ritu Raman, co-first author of the study. “But why stop there? We can go beyond this by using the dynamic abilities of cells to self-organize and respond to environmental cues to forward engineer non-natural biological machines and systems.”
“The idea of doing forward engineering with these cell-based structures is very exciting,” Prof. Bashir commented. “Our goal is for these devices to be used as autonomous sensors. We want it to sense a specific chemical and move towards it, then release agents to neutralize the toxin, for example. Being in control of the actuation is a big step forward toward that goal.”
Related Links:
University of Illinois at Urbana-Champaign
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more
Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more
Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read moreMolecular Diagnostics
view channel
New DNA Test Diagnoses Bacterial Infections Faster and More Accurately
Antimicrobial resistance has emerged as a significant global health threat, causing at least one million deaths annually since 1990. The Global Research on Antimicrobial Resistance (GRAM) Project warns... Read more
Innovative Bio-Detection Platform Improves Early Cancer Screening and Monitoring
Cancer remains one of the leading causes of death globally, underscoring the critical need for more advanced, efficient, and early detection methods. Circulating tumor cells (CTCs) are cells that have... Read more
Blood Test Could Help More Women Survive Aggressive Triple Negative Breast Cancer
Cancer research shows that over 90% of women diagnosed with breast cancer at its earliest stage survive for five years or more. However, this survival rate dramatically decreases to just 30% when the cancer... Read moreHematology
view channel
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
WBC Count Could Predict Severity of COVID-19 Symptoms
The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more
New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more
Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read moreImmunology
view channelCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more
Rapid PCR Testing in ICU Improves Antibiotic Stewardship
A collaborative study led by the University of Plymouth (Devon, UK) has shown that rapid polymerase chain reaction (PCR) testing in the intensive care unit (ICU) improved antibiotic stewardship compared... Read morePathology
view channel
Informatics Solution Elevates Laboratory Efficiency and Patient Care
QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread
Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis
Tissue analysis typically involves a pathologist reviewing scanned digital slides from a patient’s intestinal sample and marking specific areas, such as those where cancerous and related tissues are present.... Read moreTechnology
view channel
POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
Cardiovascular diseases continue to be the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of myocardial infarction (MI), commonly known as a heart... Read more
Study Explores Impact of POC Testing on Future of Diagnostics
In today’s rapidly changing world, having quick and accurate access to medical information is more crucial than ever. Point-of-Care Diagnostics (PoC-D) and Point-of-Care Testing (PoC-T) are making this... Read more
Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
Cancer biomarkers are valuable tools for early diagnosis as their concentration in body fluids, such as serum, can be measured to detect the disease at an earlier stage. Additionally, serum levels of these... Read moreIndustry
view channel
CACLP 2025 Unites Global Innovators in IVD Industry
CACLP (Shanghai, China) will be holding the 22nd China International In Vitro Diagnostic Expo, the largest and most influential gathering of the IVD industry in China, 22-24 March 2025 at the Hangzhou... Read more
Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
Bio-Rad Laboratories (Hercules, CA, USA) has entered into a binding offer to purchase all equity interests in Stilla Technologies (Villejuif, France). The acquisition remains subject to consultation with... Read more